Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum9512210.26442/2075-1753_2018.10.91-94ArticlesСтатьиResearch ArticleThickness of epicardial adipose tissue as a predictor of cardiovascular riskТолщина эпикардиальной жировой ткани как предиктор кардиоваскулярного рискаDavydovaA. VДавыдоваАнна Владимировна

врач-кардиолог Регионального сосудистого центра

NikiforovV. SНикифоровВиктор Сергеевич

д-р мед. наук, проф., проф. каф. функциональной диагностики

viktor.nikiforov@szgmu.ruKhalimovYu. SХалимовЮрий Шакатович

д-р мед. наук, проф., нач. каф. военно-полевой терапии

yushkha@gmail.comA.S.Lukashevskiy Kamchatka Regional Hospital. 630003, Russian FederationГБУЗ «ККБ им. А.С. Лукашевского»I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian FederationФГБОУ ВО «СЗГМУ им. И.И.Мечникова»S.M.Kirov Military Medical Academy of the Ministry of Defence of the Russian FederationФГБВОУ ВО «ВМА им. С.М.Кирова»151020182010VOL 20, NO10 (2018)ТОМ 20, №10 (2018)919428122021Copyright ©; 2018, Consilium MedicumCopyright ©; 2018, ООО "Консилиум Медикум"2018Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/95122

Epicardial fat is one of the most discussed and unexplored risk factor for cardiovascular disease. Structure of epicardial adipose tissue, it’s functions and pathophysiological processes are observed. It is considered epicardial fat to increase cardiovascular risk. Currently, there is no standardized methodology for measuring the thickness of the epicardial fat. As the most accessible method, the method of transthoracic echocardiography is considered and described.

Эпикардиальный жир - один из наиболее обсуждаемых и до конца не изученных факторов риска развития сердечно-сосудистых заболеваний. Рассматривается вопрос строения эпикардиальной жировой ткани, ее функции и патофизиологических процессов, которые приводят, как предполагается, к повышению кардиоваскулярного риска. В настоящее время не существует общепринятых стандартизованных методик по измерению толщины эпикардиального жира. В качестве наиболее доступного метода рассмотрен и описан метод трансторакальной эхокардиографии.

epicardial fatcardiovascular diseasecardiovascular riskechocardiographyэпикардиальная жировая тканьсердечно-сосудистые заболеваниякардиоваскулярный рискэхокардиографияPiepoli M.F, Hoes A.W, Agewall S et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37 (29): 2315-81.Lavie C.J, Milani R.V, Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925-32.Чумакова Г.А., Веселовская Н.Г. Методы оценки висцерального ожирения в клинической практике. Рос. кардиолог. журн. 2016; 21 (4): 89-96.Iacobellis G, Corradi D, Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2 (10): 536-43.Бубнова М.Г. Роль ожирения и висцерального жира сердца в запуске сердечно-сосудистого континуума. Клинические эффекты орлистата. Рос. мед. журн. 2014; 22 (2): 116-22.Wu Y, Zhang A, Hamilton D.J, Deng T. Epicardial Fat in the Maintenance of Cardiovascular Health. Methodist Debakey Cardiovasc J 2017; 13 (1): 20-4.Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring) 2009; 17 (4): 625; author reply 626-627.Драпкина О.М., Корнеева О.Н., Драпкина Ю.С. Эпикардиальный жир: нападающий или запасной? Рацион. фармакотерапия в кардиологии. 2013; 9 (3): 287-91.Turer A.T, Scherer P.E. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012; 55 (9): 2319-26.Ouchi N, Parker J.L, Lugus J.J, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11 (2): 85-97.Wong H.K, Cheung T.T, Cheung B.M. Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc Dis 2012; 1 (5): pii: cvd.2012.012003.Hirata Y, Kurobe H, Akaike M et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J 2011; 52 (3): 139-42.Rajsheker S, Manka D, Blomkalns A.L et al. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 2010; 10 (2): 191-6.Mazurek T, Zhang L, Zalewski A et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108 (20): 2460-6.Ito T, Nasu K, Terashima M et al. The impact of epicardial fat volume on coronary plaque vulnerability: insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging 2012; 13 (5): 408-15.Sacks H.S, Fain J.N et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 2009; 94 (9): 3611-5.Никифоров В.С., Никитин А.Э., Тыренко В.В., Свистов А.С. Ишемическая дисфункция миокарда. М.: АПКиППРО, 2005.Pezeshkian M, Noori M, Najjarpour-Jabbari H et al. Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord 2009; 7 (2): 125-31.Prati F, Arbustini E, Labellarte A et al. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? Eur Heart J 2003; 24: 329-36.Iacobellis G, Ribaudo M.C, Zappaterreno A et al. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004; 94 (8): 1084-7.Hirata Y, Tabata M, Kurobe H et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58 (3): 248-55.Weisberg S.P, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12): 1796-1808.Baker A.R, Harte A.L, Howell N et al. Epicardial adipose tissue as a source of nuclear factor-kB and c-Jun N-terminal kinase medi-ated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 2009; 94 (1): 261-7.Berg A.H, Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96 (9): 939-49.Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 2015; 11 (6): 363-71.Bertaso A.G, Bertol D, Duncan B.B et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol 2013; 101 (1): e18-e28.Salgado-Somoza A, Teijeira-Fernandez E, Fernandez A.L et al. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am J Physiol Heart Circ Physiol 2010; 299 (1): H202-H209.Alexopoulos N, McLean D.S, Janik M et al. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010; 210 (1): 150-4.Iacobellis G, Willens H.J, Barbaro G, Sharma A.M. Threshold values of highrisk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 2008; 16 (4): 887-92.Jeong J, Jeong M.H, Yun K.H et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71 (4): 536-9.Nelson M.R, Mookadam F, Thota V et al. Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification? J Am Soc Echocardiogr 2011; 24 (3): 339-45.